Latest News & Features
Americas
The Federal Circuit has brought Paxloid’s infringement case to an end, serving as a reminder that even minor changes to patent language can have major consequences. 25 June 2026
Biotechnology
Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm to develop new medicines. 25 June 2026
Europe
A UK judge extends a blocking order aimed at ISPs including BT, EE, and Sky, allowing the maker of Ozempic and Wegovy to add infringing sites that sell counterfeits without returning to court. 25 June 2026
Africa
Weight loss drugs promise a diabetes breakthrough in Africa, but patent barriers stall access. What does COVID-19 tell us about how to solve the continent’s silent crisis? Asks Sofia Araújo of Inventa. 24 June 2026
Careers
The pair bring a strong track record advising life sciences companies on licensing, collaboration and commercialisation agreements, with a particular focus on cross-border biotech transactions. 23 June 2026
Biotechnology
The partnership, announced at BIO 2026, marks the largest Asia-Pacific partnership by potential value that the AI-driven drug discovery company has secured to date. 22 June 2026
Asia
The court granted Blue Cross Laboratories a permanent injunction after finding that a rival product’s mark and packaging closely mirrored its own. 22 June 2026
Europe
The court overturns a decision granting the German-based company provisional measures and ordering a Chinese medtech rival to stop selling its device in four European countries. 19 June 2026
Big Pharma
Despite a slowdown in US patent litigation, life sciences remains one of the most active sectors—but companies are using a wider than ever IP toolkit, says a new study. 18 June 2026
Careers
With more than 25 years of experience as a commercial and IP lawyer, the firm’s new partner previously led the legal function at a pioneering UK company. 18 June 2026